Cartilage repair: generations of autologous chondrocyte transplantation.
Articular cartilage in adults has a limited capacity for self-repair after a substantial injury. Surgical therapeutic efforts to treat cartilage defects have focused on delivering new cells capable of chondrogenesis into the lesions. Autologous chondrocyte transplantation (ACT) is an advanced cell-based orthobiologic technology used for the treatment of chondral defects of the knee that has been in clinical use since 1987 and has been performed on 12,000 patients internationally. With ACT, good to excellent clinical results are seen in isolated post-traumatic lesions of the knee joint in the younger patient, with the formation of hyaline or hyaline-like repair tissue. In the classic ACT technique, chondrocytes are isolated from small slices of cartilage harvested arthroscopically from a minor weight-bearing area of the injured knee. The extracellular matrix is removed by enzymatic digestion, and the cells are then expanded in monolayer culture. Once a sufficient number of cells has been obtained, the chondrocytes are implanted into the cartilage defect, using a periosteal patch over the defect as a method of cell containment. The major complications are periosteal hypertrophy, delamination of the transplant, arthrofibrosis and transplant failure. Further improvements in tissue engineering have contributed to the next generation of ACT techniques, where cells are combined with resorbable biomaterials, as in matrix-associated autologous chondrocyte transplantation (MACT). These biomaterials secure the cells in the defect area and enhance their proliferation and differentiation.
Marlovits
Stefan
S
Department of Traumatology, Center for Joint and Cartilage, Medical University of Vienna, Austria. stefan.marlovits@meduniwien.ac.at
Zeller
Philip
P
Singer
Philipp
P
Resinger
Christoph
C
Vécsei
Vilmos
V
D002357:Cartilage Diseases / Q000209:etiology / Q000517:prevention & control; D002358:Cartilage, Articular / Q000293:injuries* / Q000601:surgery*; D017690:Cell Transplantation / Q000379:methods; D019902:Chondrocytes / Q000637:transplantation*; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007718:Knee Injuries / Q000601:surgery*; D019637:Orthopedic Procedures / Q000379:methods*; D018579:Patient Selection; D023822:Tissue Engineering / Q000379:methods*; D014182:Transplantation, Autologous